Shingles: A review of diagnosis and management

Hospital Medicine

Volumn 59, Issue 10, 1998, Pages 770-776

  Morgan, Rosemary ^a   King, Debra ^a  

^a WIRRAL UNIVERSITY TEACHING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

AIDS RELATED COMPLEX; CHICKENPOX; FEMALE; HERPES ZOSTER; HUMAN; ISOLATION AND PURIFICATION; REVIEW; VARICELLA ZOSTER VIRUS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CHICKENPOX; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS;

EID: 0032193377     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Adour KK (1994) Otological complications of herpes zoster. Ann Neurol 5: S62-S64
2. Arvin AM (1996) Varicella zoster virus: overview and clinical manifestations. Semin Dermatol 15: 4-7
3. Bean B, Braun C, Balfour HH (1982) Acyclovir therapy for acute herpes zoster. Lancet ii: 118-21
4. Birinyi F (1996) Facial weakness and rash. Acad Emerg Med 3: 1144-55
5. Bowsher D (1994a) The effects of acyclovir therapy for her pes zoster on treatment outcome in postherpetic neuralgia. Eur J Pain 15: 1
6. Bowsher D (1994b) Post-herpetic neuralgia in older patients: incidence and optimal treatment. Drugs Aging 6: 411-18
7. Devries PR Moesker WH (1988) The natural history of facial paralysis in herpes zoster. Clin Otolaryngol 13: 289-98
8. Elsiri MM, Tomlinson AH (1972) Herpes zoster: demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci 15: 35-48
9. Esman V, Geil J, Kroon S (1987) Prednisolone does not prevent post herpetic neuralgia. Lancet ii: 126
10. Galbraith AW (1973) Treatment of herpes zoster with amantadine hydrochloride (Symmetrel). Br Med J iv: 693-5
11. Groth KE, McCullough J, Marker SC (1978) Evaluation of zoster immune plasma:treatment of cutaneous disseminated zoster in immunocompromised patients. JAMA 239: 1877-9
12. Hope-Simpson R (1965) The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58: 9
13. Hope-Simpson RE (1975) Post herpetic neuralgia. J R Coll Gen Pract 25: 571-5
14. Hull JC (1989) Oral acyclovir therapy in acute herpes zoster: a multicentre study. Res Clin Forums 9: 37-43
15. Hull JC, Bean B, Balfour HH (1988) Therapy of herpes zoster with oral acyclovir. Am J Med 85 (Suppl 2A): 84-9
16. Jacobson MA (1993) Valaciclovir (BW 256U87): the l-valyl ester of acyclovir. J Med Virol 1 (Suppl): 150-3
17. Johnson R (1995) (Chairman of the Working Group) Guidelines for the Management of Shingles: Report of a working group of the British Society for the Study of Infection (BSSI). J Infect 30: 193-200
18. Mandal BK, Dunbar EM, Ellis J, Dowd P (1988) A double masked placebo controlled trial of acyclovir cream in immunocompetent patients with herpes zoster. J Infect 17: 57-63
19. McKendrick M, McGill J, White J (1986) Oral acyclovir in acute herpes zoster. Br Med J 293: 1629
20. Melbye M, Grossman RJ, Goebert JJ et al (1987) Risk of AIDS after herpes zoster. Lancet i: 728-30
21. Merigan TC, Rand KH, Pollard RB (1978) Human leucocyte interferon for the treatment of herpes zoster with cancer. N Engl J Meet 298: 981-7
22. Morgan R, King D (1998) Characteristics of patients with shingles admitted to a district general hospital. Postgrad Med J 14: 101-3
23. Morton P, Thomson AN (1989) Oral acyclovir in the treatment of herpes zoster in general practice. NZ Med J 102: 93-5
24. Muecke M (1993) Herpes zoster oticus. J Louisiana State Med Soc 145: 333-5
25. Murakami S, Hato N, Horiuchi J, Honda N, Gyo K, Yanagihara N (1997) Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol 41: 353-7
26. Nahass GT, Goldstein BA, Zhu WY (1992) Comparison of Tzanck-smear, viral culture and DNA diagnostic methods in detection of herpes simplex and varicella zoster infection. JAMA 268: 2541-4
27. Nikkels AF, Debrus S, Sadzot-Delvaux C et al (1993) Comparative immunohistochemical study of herpes simplex and varicella zoster infections. Virchows Archiv A 422: 121-6
28. Peterslund NA, Ipsen J, Schonheyder H (1981) Acyclovir in herpes zoster. Lancet ii: 827-30
29. Rothrock JF, Walicke PA, Swenson MR (1986) Neurogenic bladder from occult herpes zoster. Postgrad Med 80: 211-3
30. Tricot G, DeClercq E, Boogaerts MA (1986) Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella zoster virus infections in severely immunosuppressed patients: a preliminary clinical trial. J Med Virol 18: 11-20
31. Wagstaff AJ, Faulds D, Goa KL (1994) Aciclovir: a reappraisal of its antiviral activity, pharmokinetic properties and therapeutic efficacy. Drugs 47: 153-205
32. Whitley R, Chien LT, Dolin R (1976) Adenine arabinoside therapy of herpes zoster in the immunosuppressed. N Engl J Med 294: 1193-9
33. Whitley RJ, Gnann JW, Hinthorn D (1992) Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidabarine. J Infect Dis 165: 450-5
34. Wildenhoff KE, Esmann V, Ipsen J, Harving H, Peterslund NA, Schonheyder H (1981) Treatment of trigeminal and thoracic zoster with idoxuridine. Scand J Infect Dis 13: 257-62
35. Wood MJ, Ogan PH, McKendrick MW (1988) Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 85(Suppl 2A): 79-83
36. Vere Hodge RA, Cheng YC (1993) The mode of action of penciclovir. Antiviral Chem Chemother 4 (Suppl): 13-24